Tower View Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Tower View Wealth Management's PFE Position: Q1 2026 in Review
Tower View Wealth Management increased its Pfizer (PFE) stake by 1.6% in Q1 2026, buying an estimated $506 and bringing the position to 1,240 shares worth $34.8K. The position accounts for 0.02% of the portfolio, ranked #105.
Tower View Wealth Management first reported a position in PFE in Q4 2017 and has held it in 23 quarters since. The position peaked at $64K in Q3 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Tower View Wealth Management held 1,240 shares of Pfizer worth $34.8K as of Q1 2026.
- Tower View Wealth Management bought 19 Pfizer shares in Q1 2026, an estimated $506.
- Pfizer made up 0.02% of Tower View Wealth Management's portfolio in Q1 2026, its #105 holding.
- Tower View Wealth Management first reported a position in Pfizer in Q4 2017 and has held it in 23 quarters since.
- Tower View Wealth Management's Pfizer position peaked at $64K in Q3 2023.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Tower View Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.